MedPath

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

Completed
Conditions
Vaginal Prolapse
Interventions
Device: AMS Prolapse Product
Registration Number
NCT00388947
Lead Sponsor
ASTORA Women's Health
Brief Summary

This registry was observational (only collected information typically noted by the surgeon when their patients were routinely seen); there was no change to the care the patient received as a result of being part of the registry). Data collection focused on the surgical outcomes of AMS prolapse products.

Detailed Description

The Prolapse Registry was an observational study of patients who were implanted with AMS devices for the surgical repair of female pelvic prolapse. The registry followed patients post-operatively for up to 2 years and collected demographic, clinical, surgical, safety, and patient outcomes data.

The registry was a web-based system in which surgeons entered patient information with regard to their prolapse surgery. All information entered was de-identified (no names, no date of birth, no date of surgery, etc).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1543
Inclusion Criteria
  • Female at least 21 years old
  • Has pelvic organ prolapse requiring surgical repair
  • Receives at least one of the AMS Prolapse Repair devices in the treatment of their pelvic organ prolapse
Exclusion Criteria
  • Is contraindicated for an AMS Prolapse Repair per the product's Instruction for Use.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1AMS Prolapse ProductAMS Prolapse Product (AMS Apogee™ with IntePro (Synthetic) or InteXen (Biologic) Mesh implant for posterior wall pelvic organ prolapse AMS Straight-In™ with IntePro (Synthetic) Mesh implant for vaginal vault pelvic organ prolapse AMS Perigee™ with IntePro Mesh implant for anterior wall pelvic organ prolapse AMS Perigee™ with IntePro Mesh coated with PC AMS Elevate® Prolapse Repair System Family)
Primary Outcome Measures
NameTimeMethod
Count of Patients With at Least One Adverse Event Related to Any AMS Prolapse Deviceup to 2-years post-implant
Secondary Outcome Measures
NameTimeMethod
Prolapse Efficacy Success Rate24 months

Success was defined as either (1) Baden-Walker grade 0 or 1 or (2) (Pelvic Organ Prolapse Quantification System) POP-Q stage 0 or 1. If a site reported both measurements, then the POP-Q score was used.

Trial Locations

Locations (1)

Samuel Zylstra, MD

🇺🇸

Whitinsville, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath